Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA217667
Max Phase: Preclinical
Molecular Formula: C53H70N2O13
Molecular Weight: 943.14
Molecule Type: Small molecule
Associated Items:
ID: ALA217667
Max Phase: Preclinical
Molecular Formula: C53H70N2O13
Molecular Weight: 943.14
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C#CC[C@H](/C=C/C(C)=C/[C@@H](O)[C@H]1C[C@@H](OC)C[C@@](O)(Cc2nc(/C=C(\C)[C@@H]3O[C@@H]4C/C=C/c5nc(co5)[C@H]5C[C@H](O)C[C@@H](C[C@H]6CC(=C)C[C@H](C/C=C\C(=O)O[C@@H]([C@H]4C)[C@H]3C)O6)O5)co2)O1)OC
Standard InChI: InChI=1S/C53H70N2O13/c1-9-12-38(60-7)18-17-31(2)21-44(57)47-26-42(61-8)27-53(59,68-47)28-49-54-36(29-62-49)22-33(4)51-35(6)52-34(5)45(66-51)14-11-15-48-55-43(30-63-48)46-24-37(56)23-41(65-46)25-40-20-32(3)19-39(64-40)13-10-16-50(58)67-52/h1,10-11,15-18,21-22,29-30,34-35,37-42,44-47,51-52,56-57,59H,3,12-14,19-20,23-28H2,2,4-8H3/b15-11+,16-10-,18-17+,31-21+,33-22+/t34-,35-,37+,38+,39-,40+,41-,42+,44+,45+,46+,47+,51-,52-,53-/m0/s1
Standard InChI Key: DFCPSFLWZFKTME-ZFLJMKJUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 943.14 | Molecular Weight (Monoisotopic): 942.4878 | AlogP: 7.48 | #Rotatable Bonds: 11 |
Polar Surface Area: 194.43 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.50 | CX Basic pKa: 0.16 | CX LogP: 5.36 | CX LogD: 5.36 |
Aromatic Rings: 2 | Heavy Atoms: 68 | QED Weighted: 0.09 | Np Likeness Score: 1.77 |
1. Uckun FM, Forsyth CJ.. (2001) Anticancer activity of synthetic analogues of the phorboxazoles., 11 (9): [PMID:11354372] [10.1016/s0960-894x(01)00191-3] |
Source(1):